GENE ONLINE|News &
Opinion
Blog

2026-06-03|

Illicit Cigarette Consumption in EU Exceeds 10 Percent as Counterfeit Products Become Primary Driver

by GOAI
Share To

The illicit cigarette market in the European Union surpassed 10% of total consumption in 2025, marking the first time the region has reached this threshold since 2014. Data indicates that counterfeit products now serve as the primary driver of this growth, replacing the previous trend of illicit white cigarettes as the dominant source of untaxed tobacco.

The findings show that total illicit consumption reached 35.2 billion cigarettes last year, representing a 0.8 percentage point increase from 2024. Counterfeit cigarettes accounted for 13.5 billion of those units, a significant rise that reflects shifting patterns in illegal trade. While illicit white cigarettes—brands manufactured specifically for smuggling—previously accounted for the largest share of the black market, counterfeit versions of established mainstream brands now occupy that position. Law enforcement and industry analysts attribute this shift to evolving supply chain tactics and the continued demand for lower-priced tobacco products across EU member states.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 3, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Braskem Adds Blooming Future Vessel to Maritime Logistics Fleet
2026-06-18
Health Officials Investigate Infant Botulism Outbreak Linked to ByHeart and Nara Formula Products
2026-06-18
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
2026-06-18
PNC Multifamily Capital Launches $251.4 Million Affordable Housing Investment Fund
2026-06-18
ArcelorMittal, thyssenkrupp, and voestalpine Call for EU Emissions Trading System Reforms to Protect Steel Competitiveness
2026-06-18
Hillman Group and Hillwood Begin Construction on Dallas-Fort Worth Multipurpose Facility
2026-06-18
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
2026-06-18
Scroll to Top